Skip Navigation


ToxSci Advance Access originally published online on September 28, 2005
Toxicological Sciences 2006 89(1):75-82; doi:10.1093/toxsci/kfi344
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
89/1/75    most recent
kfi344v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Patel, R. D.
Right arrow Articles by Perdew, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, R. D.
Right arrow Articles by Perdew, G. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The Aryl Hydrocarbon Receptor Directly Regulates Expression of the Potent Mitogen Epiregulin

Rushang D. Patel, Dae Joon Kim, Jeffrey M. Peters and Gary H. Perdew1

Graduate Programs in Molecular Medicine and Molecular Toxicology, The Huck Institutes of the Life Sciences, Department of Veterinary Science and The Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania 16802

Received June 27, 2005; accepted September 20, 2005

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is known to cause a large number of adverse effects, mediated largely by its binding to the aryl-hydrocarbon receptor (AhR) and subsequent modulation of gene expression. It is thought that AhR mediates these effects through the untimely and disproportionate expression of specific genes. However, the exact mechanism, or the genes involved, through which TCDD leads to these effects is still unknown. This study reports the discovery of a novel target gene, epiregulin, which is regulated by TCDD-activated AhR. Epiregulin is a growth regulator which belongs to the epidermal growth factor (EGF) family. Using real time quantitative PCR (qPCR), it was established that TCDD upregulates epiregulin gene expression. The promoter region of epiregulin has a dioxin responsive element (DRE) 56 nucleotides upstream of the transcription start site, along with three potential Sp1 binding sites. Chromatin immunoprecipitation (ChIP) assays with an anti-AhR antibody showed promoter occupancy upon TCDD treatment. Luciferase reporter assays using a vector harboring the first 125 base pairs of the epiregulin rat promoter revealed an increase in signal on TCDD treatment, which was lost upon mutation of the DRE. Epiregulin and TCDD treatment mediated a dose-dependent increase in primary mouse keratinocyte growth. These results demonstrate that AhR directly increases epiregulin expression, which could play an important role in TCDD mediated tumor promotion observed in rodent models.

Key Words: AhR; epiregulin; transcription; growth factor; TCDD.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
Christopher. R. Chiaro, R. D. Patel, and Gary. H. Perdew
12(R)-Hydroxy-5(Z),8(Z),10(E),14(Z)-eicosatetraenoic Acid [12(R)-HETE], an Arachidonic Acid Derivative, Is an Activator of the Aryl Hydrocarbon Receptor
Mol. Pharmacol., December 1, 2008; 74(6): 1649 - 1656.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Li, F. Takeuchi, J.-a. Wang, Q. Fan, T. Komurasaki, E. M. Billings, G. Pacheco-Rodriguez, J. Moss, and T. N. Darling
Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas
PNAS, March 4, 2008; 105(9): 3539 - 3544.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Belguise, S. Guo, S. Yang, A. E. Rogers, D. C. Seldin, D. H. Sherr, and G. E. Sonenshein
Green Tea Polyphenols Reverse Cooperation between c-Rel and CK2 that Induces the Aryl Hydrocarbon Receptor, Slug, and an Invasive Phenotype
Cancer Res., December 15, 2007; 67(24): 11742 - 11750.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Rumelhard, K. Ramgolam, R. Hamel, F. Marano, and A. Baeza-Squiban
Expression and role of EGFR ligands induced in airway cells by PM2.5 and its components
Eur. Respir. J., December 1, 2007; 30(6): 1064 - 1073.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. Wu, L. Zhang, M. S. Hoagland, and H. I. Swanson
Lack of the Aryl Hydrocarbon Receptor Leads to Impaired Activation of AKT/Protein Kinase B and Enhanced Sensitivity to Apoptosis Induced via the Intrinsic Pathway
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 448 - 457.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
S. SH. Choi, M. A. Miller, and P. A. Harper
In Utero Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Amphiregulin Gene Expression in the Developing Mouse Ureter
Toxicol. Sci., November 1, 2006; 94(1): 163 - 174.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.